Summary
This 8-K filing from Exelon Corporation on June 1, 2006, details remarks made by CEO John W. Rowe at the Sanford C. Bernstein & Co. Strategic Decisions Conference. The presentation focused on the company's strategic evolution driven by industry restructuring and its proposed merger with Public Service Enterprise Group Incorporated (PSEG). Rowe highlighted Exelon's successful shift towards a larger proportion of earnings derived from its competitive generation business, Exelon Generation (ExGen), which grew from 22% of operating earnings in 2002 to 50% in 2005. This strategic focus has led to significantly improved financial performance and a strong market valuation. The filing also provides an update on the proposed merger with PSEG, acknowledging delays and increased market uncertainty due to rising energy prices and regulatory responses. Despite these challenges, Exelon remains committed to the merger, emphasizing its strategic fit and potential to create shareholder value. The company is actively engaged in discussions with the DOJ and regulators in New Jersey, and has retained Lazard as an additional advisor to reassess the transaction's economic attractiveness. Exelon believes the relative value of both companies has increased proportionally and the strategic rationale remains intact, pending favorable regulatory settlements.
Key Highlights
- 1Exelon's strategic shift towards competitive generation business (ExGen) has significantly increased its contribution to operating earnings, rising from 22% in 2002 to 50% in 2005.
- 2The company attributes its strong financial performance and high market valuation (over $35 billion in year-end capitalization) to this strategic restructuring and improved operating efficiency.
- 3Exelon's generation fleet demonstrated exceptional operational performance in 2005, with a nuclear fleet capacity factor of 93.5% and a fossil fleet commercial availability of 95.7%.
- 4The proposed merger with Public Service Enterprise Group Incorporated (PSEG) is presented as a logical extension of Exelon's strategy, combining Exelon's balance sheet and nuclear expertise with PSEG's distribution capabilities.
- 5The merger timeline has been extended due to market changes and regulatory reviews, with ongoing discussions with the DOJ and negotiations in New Jersey.
- 6Exelon has retained Lazard as an additional independent advisor to refresh its analysis of the merger's economic attractiveness.
- 7Despite market shifts, Exelon believes the relative value of both companies has increased proportionately, and the strategic value of the merger remains unchanged, contingent on regulatory settlements.